- Home
- RLAY vs SXC Comparison
RLAY vs SXC Comparison
Compare RLAY & SXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- SXC
- Stock Information
- Founded
- RLAY 2015
- SXC 1960
- Country
- RLAY United States
- SXC United States
- Employees
- RLAY N/A
- SXC N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- SXC Steel/Iron Ore
- Sector
- RLAY Health Care
- SXC Industrials
- Exchange
- RLAY Nasdaq
- SXC Nasdaq
- Market Cap
- RLAY 811.8M
- SXC 802.2M
- IPO Year
- RLAY 2020
- SXC N/A
- Fundamental
- Price
- RLAY $3.92
- SXC $9.20
- Analyst Decision
- RLAY Strong Buy
- SXC Strong Buy
- Analyst Count
- RLAY 10
- SXC 1
- Target Price
- RLAY $20.11
- SXC $13.00
- AVG Volume (30 Days)
- RLAY 1.4M
- SXC 1.0M
- Earning Date
- RLAY 02-28-2025
- SXC 01-30-2025
- Dividend Yield
- RLAY N/A
- SXC 5.24%
- EPS Growth
- RLAY N/A
- SXC 64.98
- EPS
- RLAY N/A
- SXC 1.12
- Revenue
- RLAY $10,006,000.00
- SXC $1,935,400,000.00
- Revenue This Year
- RLAY N/A
- SXC N/A
- Revenue Next Year
- RLAY N/A
- SXC $3.70
- P/E Ratio
- RLAY N/A
- SXC $8.18
- Revenue Growth
- RLAY N/A
- SXC N/A
- 52 Week Low
- RLAY $3.50
- SXC $7.47
- 52 Week High
- RLAY $10.89
- SXC $12.82
- Technical
- Relative Strength Index (RSI)
- RLAY 41.60
- SXC 34.90
- Support Level
- RLAY $3.85
- SXC $9.74
- Resistance Level
- RLAY $4.19
- SXC $10.08
- Average True Range (ATR)
- RLAY 0.28
- SXC 0.30
- MACD
- RLAY -0.02
- SXC -0.00
- Stochastic Oscillator
- RLAY 24.80
- SXC 4.84
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About SXC SunCoke Energy Inc.
SunCoke Energy Inc operates as an independent producer of coke in the Americas. The company operates through three segments: Domestic Coke, Brazil Coke, and Logistics. It offers metallurgical and thermal coal. The company also provides handling and/or mixing services to steel, coke, electric utility, coal producing, and other manufacturing-based customers.